11 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

DEPUY ACE CALCANEAL PERI-ARTICULAR PLATE

FDA 510(k)
FDA Class 2 ·Orthopedic

artegral life

FDA UDI
Merz Dental GmbH·D7091993465·anteriors; shade D3; mould BXL

FUSION SYSTEM

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

CorticaLINK Spinal Fusion Platform

FDA 510(k)
FDA Class 2 ·Orthopedic

ICON 25 HCG (COMBO CASSETTE)

FDA Adverse Event
Malfunction ·ALERE SAN DIEGO, INC.·Product code JHI·March 16, 2017

MICROFRANCE® INSTRUMENT

FDA Adverse Event
Malfunction ·XOMED MICROFRANCE MFG·Product code GEI·July 21, 2014

MOTORIZED 3-WHEELED VEHICLE FOR OUTSIDE TRANSPORT

FDA Adverse Event
C.T.M. HOMECARE PRODUCT, INC·Product code INI·March 7, 2013

CAPSUREFIX NOVUS

FDA Adverse Event
Injury ·MPRI·Product code DTB·August 8, 2014

15CC HYDROSET INJECTABLE CEMENT

FDA Adverse Event
Other ·STRYKER ORTHOPAEDICS LIMERICK·Product code GXP·February 11, 2011

ARTISTE, ONCOR Avantgarde, ONCOR Impression Plus, ONCOR Expression, PRIMUS, PRIMUS Plus, Syngo RT Therapist; therapeutic treatment of cancer Product Usage: The intended use of the SIEMENS branded ARTISTE and ONCOR family of linear accelerator systems is to deliver X-Ray photon and electron radiation for the therapeutic treatment of cancer. PRIMUSTM family of linear accelerator systems is to deliver x-ray radiation for therapeutic treatment of cancer. Syngo RT Therapist is a software application whose indication for use includes the viewing, processing, filming, and archiving of medical images. It also permits patient data management, patient selection/setup, patient positioning verification, treatment planning, treatment delivery/verification, and treatment recording.

FDA Enforcement
Class II ·Terminated·Siemens Medical Solutions USA, Inc·September 30, 2015

OPTETRAK Comprehensive Knee System including OPTETRAK Logic RBK PS Tibial Components (Product Line: 02-012-38-XXXX). NOTE: Information reflects Exactech recall expansion initiated on 02/07/2022.

FDA Enforcement
Class II ·Ongoing·Exactech, Inc.·October 13, 2021